2025-04-27 - Analysis Report
## Schrodinger Inc (SDGR) Stock Review

**0. Summary Statistics:**

SDGR, Schrodinger Inc., is a company that uses physics-based modeling and machine learning to advance drug discovery and materials science.  The stock has significantly underperformed the S&P 500 (VOO) over the given period.  Recent financial performance shows mixed results, with improving revenue but continued losses.  Technical indicators suggest the stock is currently overbought.

**1. Performance Comparison:**

* **SDGR Cumulative Return:** -40.45%
* **VOO (S&P 500) Cumulative Return:** 28.06%
* **Return Difference:** -68.5%  (This means SDGR underperformed VOO by 68.5 percentage points.)
* **Relative Divergence:** 19.2% (This places the current underperformance at the 19.2nd percentile of historical underperformance relative to the S&P 500).

**Alpha & Beta Analysis:**

The provided data shows consistently negative alpha, indicating SDGR underperformed the market benchmarks. The beta fluctuates, suggesting varying levels of market sensitivity over time. High Beta values (2.6 in 2021-2023) indicate significantly higher volatility than the market.

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|-------|--------|
| 2020-2022  | -74.0% | 68.9%  | -0.1  | 1.4   |        |
| 2021-2023  | -65.0% | 68.9%  | -0.1  | 2.6   |        |
| 2022-2024  | 8.0%   | 72.4%  | -0.1  | 1.4   |        |
| 2023-2025  | 13.0%  | 73.6%  | -0.4  | 1.9   |        |


**2. Recent Price Movement:**

* **Closing Price:** $26.45
* **5-Day Moving Average:** $26.04
* **20-Day Moving Average:** $22.40
* **60-Day Moving Average:** $22.84

The price is above both the 20-day and 60-day moving averages, suggesting a short-term upward trend.  The recent price increase from the previous close of $26.13 to $26.45 is a minor upward movement.

**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.39 (Medium Risk)
* **RSI:** 80.91 (Overbought; generally, above 70 is considered overbought)
* **PPO:** 2.22 (Positive, suggesting upward momentum)
* **20-Day Relative Divergence Change:** -2.9 (Indicates recent weakening of the upward trend)
* **Expected Return:** -238.4% (This extremely negative expected return highlights the significant risk and substantial underperformance compared to the S&P 500 for a long-term investment.)

The combination of an overbought RSI and negative relative divergence suggests a potential short-term correction. The extremely negative expected return raises significant concerns about long-term investment viability.


**4. Recent Earnings Analysis:**

SDGR has consistently reported negative EPS and relatively flat revenue.  There's no clear trend of improvement in profitability.

| Date       | EPS     | Revenue      |
|------------|---------|-------------|
| 2024-11-12 | -0.52   | $0.04 B     |
| 2024-07-31 | -0.74   | $0.05 B     |
| 2024-05-01 | -0.76   | $0.04 B     |
| 2023-11-01 | -0.86   | $0.04 B     |
| 2024-11-12 | -0.86   | $0.04 B     |


**5. Financial Information:**

Revenue has shown some quarterly increases but profitability remains questionable given the negative ROE. The high profit margins might be misleading given the low revenues and substantial losses.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31  | $0.09B   | 72.61%        |
| 2024-09-30  | $0.04B   | 50.24%        |
| 2024-06-30  | $0.05B   | 66.20%        |
| 2024-03-31  | $0.04B   | 51.61%        |
| 2023-12-31  | $0.07B   | 77.64%        |

**Capital and Profitability:**

| Quarter     | Equity   | ROE      |
|-------------|----------|----------|
| 2024-12-31  | $0.42B   | -9.54%   |
| 2024-09-30  | $0.45B   | -8.49%   |
| 2024-06-30  | $0.47B   | -11.40%  |
| 2024-03-31  | $0.51B   | -10.65%  |
| 2023-12-31  | $0.55B   | -5.59%   |


**6. Overall Analysis:**

SDGR shows significant underperformance compared to the S&P 500,  with consistently negative alpha and high volatility. While recent revenue has shown some improvement, the company remains unprofitable with negative ROE. Technical indicators suggest the stock is overbought, increasing the risk of a price correction.  The extremely negative projected return strongly cautions against long-term investment unless significant improvements in profitability and market performance are observed.  Further due diligence and a thorough risk assessment are crucial before considering any investment in SDGR.
